Acute Myeloid Leukemia (AML)

I am a 12-year-old girl who likes to play soccer and basketball, and I am in 7th grade. I was diagnosed with myelodysplastic syndromes (MDS-EB) with monosomy 7. It is a blood cancer similar to leukemia. It is extremely rare for pediatric patients to receive this diagnosis, between 1-4 children out of every million.

I’m a two-time acute myeloid leukemia (AML) survivor. I was diagnosed in 2018 and completed the 7/3 induction and consolidation then relapsed in 2020 and had a full myeloablative bone marrow transplant on May 4th, 2021, at Penn Med in Philadelphia.

I was a senior in high school preparing to graduate. I had summer plans to work at my youth group camp and endless ideas for my future. That all came crashing down on May 27, 2002, when I was diagnosed with acute myeloid leukemia (AML). AML is a rare and rapidly growing cancer of the bone marrow that destroys the production of normal blood cells, red blood cells, and platelets.

I was diagnosed with stage 4 acute myeloid leukemia (AML) in 2015. It is not known if Humira (a drug I was prescribed) caused it or just blew up the AML. On the night of diagnosis, I was told the hospital I was in could not treat me, and I would be transferred in the morning.

In 2001 at the age of 31, I was living in Maui working at the Ritz Carlton and began to feel sick. I had a rash on my hand, was tired, losing weight, and just did not feel well. I had been healthy all my life so thought it would pass.

I was diagnosed with myelodysplastic syndrome (MDS) in December of 2020. I went through six treatments from January 2021 to June 2021. The treatments were a series of shots for seven days at the beginning of the month. In July 2021, I was approved for my stem cell transplant at The James Cancer Center, The Ohio State University in Columbus, Ohio. I had my stem cell transplant on July 29.

My wife, Lynn Isaacson, was diagnosed with acute myeloid leukemia (AML) in October 2018. After three failed treatment approaches, she passed away on March 26, 2019, 162 days after diagnosis.